Moderna IncMRNA
▲ ポジティブ技術規制関連度
Its mRNA cancer therapy Intismeran Autogene with Keytruda achieved the primary endpoint in a phase 3 trial, driving the stock's 175% Q3 surge.
資産への影響 5
Biotech & Genomic Medicine
Moderna Inc
Merck & Company IncMRK
▲ ポジティブ技術関連度
Moderna's Intismeran Autogene combined with Merck's Keytruda hit the primary endpoint of recurrence-free survival in a late-stage cancer trial, a positive readout for Keytruda's use in combination therapy.
Communication Services
Warner Bros Discovery IncWBD
± 混在関連度
Named only as the company being replaced in the Nasdaq 100 by Moderna ahead of its merger with Paramount Skydance; no substantive development affecting it.
Paramount Skydance CorporationPSKY
言及
Critical Materials & Supply Chain
